AKT2 antibody (N-Term)
Quick Overview for AKT2 antibody (N-Term) (ABIN926888)
Target
See all AKT2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Cross-Reactivity
- Mouse (Murine), Rat (Rattus), Cow (Bovine), Dog (Canine)
-
Purification
- Purified
-
Immunogen
- AKT2 antibody was raised in rabbit using the N terminal of AKT2 as the immunogen
-
-
-
-
Application Notes
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
AKT2 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this AKT2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))
-
Alternative Name
- AKT2
-
Background
- AKT2 belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains. The gene encoding AKT2 was shown to be amplified and overexpressed in 2 of 8 ovarian carcinoma cell lines and 2 of 15 primary ovarian tumors. Synonyms: Polyclonal AKT2 antibody, Anti-AKT2 antibody, v-akt murine thymoma viral oncogene homolog 2 antibody, PKBBETA antibody, PRKBB antibody, RAC-BETA antibody.
-
Pathways
- PI3K-Akt Signaling, RTK Signaling, AMPK Signaling, TLR Signaling, Cellular Glucan Metabolic Process, Regulation of Carbohydrate Metabolic Process, Hepatitis C, VEGF Signaling
Target
-